{"id":194082,"name":"THE LIVINGSTON GROUP FOR TITAN PHARMACEUTICALS","slug":"the-livingston-group-for-titan-pharmaceuticals","state":"CA","country":"United States of America","description":"Pharmaceutical, makes and markets Probuphine, an implant to treat opioid addiction.","totalSpending":20000,"filings":3,"yearlySpending":[{"year":2018,"income":10000},{"year":2019,"income":10000}],"issues":[{"code":"DEF","display":"Defense"},{"code":"VET","display":"Veterans"},{"code":"PHA","display":"Pharmacy"},{"code":"LAW","display":"Law Enforcement/Crime/Criminal Justice"},{"code":"ALC","display":"Alcohol and Drug Abuse"},{"code":"HCR","display":"Health Issues"}],"firms":["CHATMAN, LLC"],"lobbyists":["PRISCILLA CHATMAN"],"govEntities":["Food & Drug Administration (FDA)","HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["FDA labeling change for Probuphine","FDA labeling change for Probuphine","FDA labeling change for Probuphine","FDA labeling change for Probuphine","Encourage federal agencies to utilize Medication Assisted Treatment (MAT) for the treatment of opioid addiction. Work for a FDA label change for probuphine."]}